13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001172661-23-001300
Total Value
$510.2M
Positions
42
Other Managers
2
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 800,000 | $38.4M | 7.52% |
| 2 | XENON PHARMACEUTICALS INC | XENE | 850,000 | $33.5M | 6.57% |
| 3 | RAPT THERAPEUTICS INC | 75382E109 | 1,436,569 | $28.4M | 5.58% |
| 4 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 3,637,718 | $26.7M | 5.24% |
| 5 | PLIANT THERAPEUTICS INC | PLRX | 1,322,870 | $25.6M | 5.01% |
| 6 | JAZZ PHARMACEUTICALS PLC | JAZZ | 160,000 | $25.5M | 5.00% |
| 7 | SEAGEN INC | SE | 160,500 | $20.6M | 4.04% |
| 8 | POINT BIOPHARMA GLOBAL INC | 730541109 | 2,541,779 | $18.5M | 3.63% |
| 9 | NOVOCURE LTD | NVCR | 241,000 | $17.7M | 3.46% |
| 10 | IVERIC BIO INC | 46583P102 | 825,000 | $17.7M | 3.46% |
| 11 | ACLARIS THERAPEUTICS INC | ACRS | 1,019,282 | $16.1M | 3.15% |
| 12 | HERON THERAPEUTICS INC | HRTX | 6,360,161 | $15.9M | 3.12% |
| 13 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 342,300 | $15.9M | 3.11% |
| 14 | OPTINOSE INC | 68404V100 | 7,894,736 | $14.6M | 2.86% |
| 15 | VENTYX BIOSCIENCES INC | 92332V107 | 400,695 | $13.1M | 2.58% |
| 16 | CINCOR PHARMA INC | 17240Y109 | 1,019,153 | $12.5M | 2.46% |
| 17 | VIKING THERAPEUTICS INC | VKTX | 1,295,034 | $12.2M | 2.39% |
| 18 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 544,451 | $11.7M | 2.30% |
| 19 | PTC THERAPEUTICS INC | PTCT | 302,135 | $11.5M | 2.26% |
| 20 | AEROVATE THERAPEUTICS INC | 008064107 | 378,522 | $11.1M | 2.17% |
| 21 | TRAVERE THERAPEUTICS INC | TVTX | 475,000 | $10.0M | 1.96% |
| 22 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,550,000 | $9.7M | 1.90% |
| 23 | SAREPTA THERAPEUTICS INC | SRPT | 73,000 | $9.5M | 1.85% |
| 24 | ROCKET PHARMACEUTICALS INC | RCKTW | 451,000 | $8.8M | 1.73% |
| 25 | KALVISTA PHARMACEUTICALS INC | KALV | 1,055,801 | $7.1M | 1.40% |
| 26 | AMYLYX PHARMACEUTICALS INC | AMLX | 190,000 | $7.0M | 1.38% |
| 27 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 642,566 | $6.7M | 1.32% |
| 28 | ERASCA INC | ERAS | 1,538,461 | $6.6M | 1.30% |
| 29 | INTERCEPT PHARMACEUTICALS IN | INTR | 528,850 | $6.5M | 1.28% |
| 30 | ACUMEN PHARMACEUTICALS INC | ABOS | 1,116,581 | $6.0M | 1.18% |
| 31 | MIRATI THERAPEUTICS INC | 60468T105 | 133,000 | $6.0M | 1.18% |
| 32 | VERVE THERAPEUTICS INC | 92539P101 | 300,000 | $5.8M | 1.14% |
| 33 | ALBIREO PHARMA INC | 01345P106 | 267,283 | $5.8M | 1.13% |
| 34 | LARIMAR THERAPEUTICS INC | LRMR | 1,273,635 | $5.3M | 1.03% |
| 35 | UROGEN PHARMA LTD | URGN | 560,000 | $5.0M | 0.97% |
| 36 | PRECISION BIOSCIENCES INC | DTIL | 3,801,305 | $4.5M | 0.89% |
| 37 | GRACELL BIOTECHNOLOGIES INC | 38406L103 | 1,962,399 | $4.5M | 0.88% |
| 38 | GENERATION BIO CO | 37148K100 | 1,022,537 | $4.0M | 0.79% |
| 39 | EVOLUS INC | EOLS | 190,329 | $1.4M | 0.28% |
| 40 | ALKERMES PLC | ALKS | 46,185 | $1.2M | 0.24% |
| 41 | IMMUNIC INC | IMUX | 632,184 | $885,058 | 0.17% |
| 42 | ANAPTYSBIO INC | ANABV | 15,000 | $464,850 | 0.09% |